Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-27T13:32:10.063Z Has data issue: false hasContentIssue false
  • English
  • Français

Effectiveness of Lidocaine Patch 5% in Patients With or Without Allodynia

Published online by Cambridge University Press:  07 November 2014

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
CNS Spectrums , Volume 11 , Issue 12 , December 2006 , pp. 906
Copyright
Copyright © Cambridge University Press 2006

References

1. Freeman, R. The treatment of neuropathic pain. CNS Spectr. 2005;10:698–706.Google Scholar
2. Rowbotham, MC, Davies, PS, Verkempinck, C, Galer, BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain. 1996;65:39–44.Google Scholar
3. Galer, BS, Jensen, MP, Ma, T, Davies, PS, Rowbotham, MC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 2002;18:297–301.Google Scholar
4. Barbano, RL, Herrmann, DN, Hart-Gouleau, S, et al. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol. 2004;61:914–918.Google Scholar